15-Bio ApS: Financial statements 2022
CVR: 39889277
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
15-Bio ApS (CVR 39889277) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -5,169 and a net result of DKK -3,577 compared with DKK -7,161 the year before. Equity in the 2022 report amounted to DKK 31,549. The solvency ratio was 70.4%.
- Gross Profit
- DKK -5,169
- Profit/Loss
- DKK -3,577
- Equity
- DKK 31,549
- Total Assets
- DKK 44,832
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -5 t. | -4 t. | 32 t. | - |
| 2021 | - | -6 t. | -7 t. | 35 t. | - |
| 2020 | - | -1 t. | -1 t. | 42 t. | - |
| 2019 | - | -13 t. | -22 t. | 43 t. | - |
Official annual report
Keep an eye on 15-Bio ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
15-Bio ApS has published its annual report for 2021. Gross profit came to DKK -5,750, and the net result was DKK -7,161.
About 15-Bio ApS
15-Bio ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Rasmus Jorgensen Holdings ApS and Rasmus Jorgensen IVS. The management consists of Rasmus Jørgensen. The company is owned by Rasmus Jørgensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,875 and a net result of DKK -6,875 compared with DKK -8,126 the year before. Equity in the 2025 report amounted to DKK 11,547.